{"schema_version":"secwatch.filing_event.v1","accession":"0001757898-24-000014","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.427926+00:00","generated_at":"2026-05-31T12:21:28.906540+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"STERIS Q1 FY2025 revenue $1.3B (+8%), adjusted EPS $2.03; guidance reiterated","bullets":["Total revenue from continuing ops $1.3B, up 8% YoY; constant currency organic revenue up 6%.","As-reported EPS $1.41 (from $1.31), adjusted EPS $2.03 (from $1.84).","Healthcare revenue +10% to $901.2M; AST +7% to $249.8M; Life Sciences -2% to $128.5M due to CECS divestiture.","Segment operating income all up: Healthcare $216.9M, AST $117.7M, Life Sciences $52.6M.","FY2025 guidance reaffirmed: rev growth 6.5-7.5%, adjusted EPS $9.05-$9.25, free cash flow ~$700M."],"urls":{"canonical":"https://secwatch.observer/filing/0001757898-24-000014","json":"https://secwatch.observer/filing/0001757898-24-000014.json","markdown":"https://secwatch.observer/filing/0001757898-24-000014.md","text":"https://secwatch.observer/filing/0001757898-24-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000175789824000014/0001757898-24-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000175789824000014/ste-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:21:28.906540+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}